2026 Exhibitors & Sponsors
Thank you to our 2026 Supporters!
Bronze Sponsor
Sponsors
The Global CEO Initiative on Alzheimer’s Disease (CEOi) is a collaboration of leading private sector organizations dedicated to accelerating progress in the fight against Alzheimer’s disease. By leveraging the collective influence of its members, which include pharmaceutical companies, diagnostic firms, and health technology leaders, CEOi works to shape global dialog, drive innovations in diagnostics and treatment, and increase global awareness of Alzheimer’s. The initiative is focused on addressing the growing public health crisis by fostering collaboration between industry, governments, academia, and advocacy groups to advance research, improve care, and ultimately prevent the disease.
Over the past decade, CEOi has made significant strides, notably through its efforts to foster cross-sector collaborations and push for global commitments like those made by the G7 and G20. It has played a pivotal role in advancing blood-based biomarkers and novel diagnostics that enable earlier and more accurate detection of Alzheimer’s, and in pushing forward the regulatory and clinical frameworks that support the development of these innovations. CEOi has also influenced policy discussions around Alzheimer’s funding and research, ensuring that this issue remains a priority on the global health agenda.
The Association of Academic Leaders of Neurology (AALN), pronounced All In, is the only organization focused exclusively on developing leaders in academic neurology. Through personalized coaching, peer connection, and real‑world leadership education, AALN equips educators, Chairs, and rising leaders to advance scholarship, strengthen education, and elevate the field of neurology.
Eisai Inc. is a human health care (hhc) company dedicated to pursuing innovative research and simplifying the treatment journey to help improve the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions. Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.
Our hhc mission is the shared purpose that connects us to those we serve. It creates a network of powerful relationships that enable us to identify, understand and address unmet needs and healthcare disparities as we work towards achieving societal good.
Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. Our U.S. operations include discovery, research and development, manufacturing, global supply and logistics, and commercial activities.
To learn more, please visit https://us.eisai.com and connect with us on X and LinkedIn. For more information on our research, follow our dedicated neurology (LinkedIn and X) and oncology (LinkedIn and X) pages.
https://www.medlearninggroup.com/
Med Learning Group is a full-service accredited CME provider that develops innovative, case-based, and patient-centric educational activities. We enhance physicians’, nurses’, and healthcare professionals’ ability to deliver optimal care, applying adult learning principles to achieve high-quality outcomes for both practitioners and patients
Sutter Health is a leading healthcare system delivering high-quality, patient-centered care across California. Through its network of hospitals, clinics, and physicians, Sutter’s medical groups and care teams offer a broad range of services and specialties designed to meet patients’ evolving needs. A strong commitment to innovation and collaboration drives the organization’s ability to deliver exceptional care and improve the health of the communities it serves. Sutter Health was recently recognized by Forbes as one of America’s Best Large Employers. To explore current opportunities, visit: https://jobs.sutterhealthclinicians.org/.
https://www.wiley.com/en-us/publish/article/author-resources/
Wiley champions those who see knowledge as a force for good. A trusted leader in research and learning, our pioneering solutions and services are paving the way for knowledge seekers as they work to solve the world’s most important challenges. Around the globe, we break down barriers for innovators, empowering them to publish and advance discoveries in their fields, evolve their workforces, and shape minds through teaching and learning. Together, we are unlocking the creation and curation of knowledge for all, transforming today’s biggest obstacles into tomorrow’s brightest opportunities.
Academic and Institutional Supporters
In neurology, we diagnose and treat your brain, spine, nervous system and muscle disorders.
There are over 600 neurological disorders, but we match that complexity with our fellowship trained, specialized providers.
Our approach to neurology
Our goal is to provide you with patient-centered, individualized and compassionate care. We offer you evidence-based medicine with a holistic, integrated approach.
How we work together
Neurology is an intricate and complex field. Your brain, spinal cord and nervous system are responsible for managing:
Your senses – what you see, hear, feel, touch and taste
How you move
Your cognitive ability, thoughts and feelings
Involuntary activities like breathing, heart pumping and metabolic processes
Body activities like temperature control, blood pressure, thirst, hunger and digestion
Your case is unique, but you can expect to work with a highly specialized team based on your diagnosis. We are naturally collaborative and work across multiple departments to provide the most accurate diagnosis and the best treatment options. Our team will coordinate your access to care across our subspecialties.
The advantages of an academic hospital
The benefits to you include:
Highly integrated network of generalist and specialist providers
Access to the most sophisticated diagnostic testing and the latest treatments
Leading-edge research on the future of medicine and neurological advances
Includes access to clinical trials that offer hope for complex neurological issues
In fact, we have over a hundred clinical trials taking place in neurology. At UCI Health, the gold standard in medicine, the latest treatments and integrative add-ons such as acupuncture and Tai-Chi are all available.
Exhibitors
Driven by urgency and the reality that too many patients have few or no treatment options, we are committed to advancing where others hesitate. Inspired by the patients and families who count on us, Acadians across North America, Europe, and beyond dedicate their work to advancing therapies in underserved neurological disorders and rare diseases. Their collective expertise drives innovations that bring meaningful moments and brighter futures to patients and loved ones around the world.
https://www.accesstelecare.com
Access TeleCare is the national leader in acute specialty telemedicine, having launched more than 2,600 telemedicine programs and partnered with 1 in 5 U.S. hospitals across all 50 states. As a pioneer in tech-enabled virtual care for the last 20+ years, the company has grown to now deliver care in more than 1 million patient encounters annually across multiple specialty service lines, including behavioral health, neurology, hospitalist medicine, pulmonary and critical care, maternal-fetal medicine, infectious disease, cardiology, and nephrology. The virtual care provided by Access TeleCare is crucial in ensuring timely and high-quality healthcare coverage across a geographic area that represents more than 65% of the U.S. population, approximately 216 million Americans, many of whom live in medically underserved, vulnerable, or rural areas. As the first and longest-standing telemedicine organization to receive The Joint Commission’s Gold Seal of Approval in 2006, Access TeleCare is leading the way to a better healthcare delivery system with clinically excellent tech-enabled services.
Alexion, AstraZeneca Rare Disease, is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and delivery of life-changing medicines. A pioneering leader in rare disease for more than three decades, Alexion was the first to translate the complex biology of the complement system into transformative medicines, and today it continues to build a diversified pipeline across disease areas with significant unmet needs using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients throughout the world. It is headquartered in Boston, US.
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines, helping make people’s lives easier, fuller and longer.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat heart disease, obesity and obesity-related conditions, rare diseases, inflammatory conditions and cancer.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit argenx.com
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Axsome delivers scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Their industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple early and late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States.
CortiCare provides nationwide EEG services, including 24/7 remote monitoring, physician interpretation, ambulatory EEG, clinical trial support, and rapid setup with CortiCap™. Our team helps healthcare organizations expand access to timely, high-quality neurological care.
Dianthus Therapeutics is developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections.
KabaFusion is a national, patient-focused home infusion company specializing in IVIG, SCIG, Chronic Specialty and Acute IV therapies.
As an industry leader, with over 30 years’ experience in home-infusion, we provide comprehensive support to our patients and providers before, during and after treatment.
We truly believe in putting the “care” back in healthcare.
Keenova is a purpose-driven therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives. We bring deep expertise and resolve to every therapeutic area we serve, including immunology, urology, orthopedics, critical care, and pediatric endocrinology. Learn more at www.keenova.com.
Kyverna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on liberating patients with autoimmune diseases through the curative potential of cell therapy. Our lead candidate, miv-cel (mivocabtagene autoleucel, KYV-101), is a fully human, autologous, CD19-targeting CAR T-cell therapy under investigation for B-cell-driven autoimmune diseases.
Since its inception in 1992, Medeia Inc. has been at the forefront of the manufacture and distribution of neurodiagnostic and heart rate variability/ANS products. Medeia Inc. specializes in the development of state-of-the-art biometrical software and hardware products intended to monitor physiology for research and educational purposes.
The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease for all people.
To support this mission, NINDS:
- Supports and performs basic, translational, and clinical neuroscience research through grants-in-aid, contracts, scientific meetings, and through research in its own laboratories, and clinics.
- Funds and conducts research training and career development programs to increase basic, translational and clinical neuroscience expertise and ensure a vibrant, talented, and diverse work force.
- Promotes the timely dissemination of scientific discoveries and their implications for neurological health to the public, health professionals, researchers, and policy-makers.
https://neurosciencesforall.org
Neurosciences for All is a 501(c)(3) non-profit dedicated to transforming lives by making neuroscience education universally accessible, regardless of geography. From foundational study to specialized clinical practice, we empower global healthcare providers with innovative educational tools and diagnostic training.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
NS Pharma is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd., committed to advancing revolutionary rare disease therapies that address unmet needs and help people live happier, healthier lives.
We serve as an in-house research center of excellence, as well as a first-class commercialization partner to clinical-stage biotechnology companies, driving life-changing scientific innovation forward.
RosmanSearch is a specialized physician recruitment firm with an edge. Our unique approach blends data-driven insights with a highly focused team of recruiters ensuring impactful placements. We don’t just fill positions; we lean on our expertise in neurosurgery, neurology, urology, gastroenterology and hospitalist medicine to curate matches that elevate healthcare standards. Whether permanent placement, executive search, or locum tenens, our experienced recruiters utilize robust data analytics and unparalleled expertise to ensure unmatched precision in every placement.
https://www.saintalphonsus.org/
Saint Alphonsus Medical Group (SAMG) is a physician-led, 650+ provider multi-specialty group committed to a multi-disciplinary team approach to patient care. Saint Alphonsus Health System (SAHS) is a growing four-hospital, 714-bed, 74 clinic integrated healthcare system serving southwestern Idaho, eastern Oregon and northern Nevada. Saint Alphonsus Health System is a member of Trinity Health, one of the largest Catholic not-for-profit health systems in the nation.
Saint Alphonsus Regional Medical Center in Boise is a designated a Level I Comprehensive Stroke Center by the Idaho Time Sensitive Emergency System, offering the highest, most comprehensive level of acute stroke care available. Saint Alphonsus Medical Center in Nampa is designated by the State of Idaho’s Time Sensitive Emergency Statewide Council (TSE) as a Level II Primary Stroke Center, having met rigorous, evidence-based benchmarks to provide rapid, highly organized, and specified stroke care.
From life-threatening injury, stroke, or disease of the brain, spinal cord, or peripheral nervous system, Saint Alphonsus experts use state-of-the-art technology to advance treatment for neurological, neurosurgical, and neurointerventional conditions to ensure that patients don’t have to travel far to get the care they need.
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. It offers OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor for the treatment of desmoid tumors; and GOMEKLI (mirdametinib), an oral small molecule inhibitor of MEK1 and MEK2 for the treatment of adult and pediatric patients two years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).
Sutter Health is a leading healthcare system delivering high-quality, patient-centered care across California. Through its network of hospitals, clinics, and physicians, Sutter’s medical groups and care teams offer a broad range of services and specialties designed to meet patients’ evolving needs. A strong commitment to innovation and collaboration drives the organization’s ability to deliver exceptional care and improve the health of the communities it serves. Sutter Health was recently recognized by Forbes as one of America’s Best Large Employers. To explore current opportunities, visit: https://jobs.sutterhealthclinicians.org/.
https://undiagnosed.hms.harvard.edu/
The Undiagnosed Diseases Network (UDN) is a research study that is funded by the National Institutes of Health. Its purpose is to bring together clinical and research experts from across the United States to solve the most challenging medical mysteries using advanced technologies.